Treatment with LAU-0901, a synthetic molecule that blocks pro-inflammatory platelet-activating factor, in addition to aspirin-triggered NPD1, reduced the size of damage areas in the brain, initiated repair mechanisms, and improved behavioral recovery following ischemic stroke.
Researchers have isolated a set of antibodies from a llama which show promise for the treatment of COVID-19. The NIH-CoVnB-112 nanoantibody bound to ACE2 receptors up to ten times stronger than other lab-produced antibodies. The nanoantibody stuck directly to the ACE2 receptor binding portion of the SARS_CoV-2 spike protein. The protein could be effective in preventing coronavirus infection.
When asked questions about sensitive behaviors, such as alcohol consumption or over-eating, people tend to respond in ways they consider socially correct, while downplaying their personal negative behaviors.
The spike protein of SARS-CoV-2 can pass through the blood-brain barrier of mice. The protein likely causes the brain to release cytokines and spark neuroinflammation. The findings add to growing evidence that COVID-19 can enter the brain of those infected by the virus.
Drinking water can suppress the vasopressin hormone receptor, mitigating obesity and metabolic syndrome in mice.
Dog owners whose pets are diabetic are more likely to develop type 2 diabetes than those with healthier pets. The study supports the hypothesis that pet owners may share certain behaviors, such as physical activity level, with their pet.
An enzyme in the colon lining releases hydrogen peroxide to help protect the body from gut microbes.
Researchers investigate how laughter improves both mental and physical well-being.
People with Parkinson's disease who have less social interaction are at greater risk for developing more severe symptoms of the disease than those who are less lonely.